Did you know?

cervical cancerIt is the female malignant tumor with the incidence rate second only to breast cancer,2020Every minute globally, there are1A new case of cervical cancer. Cervical cancer incidence in China10.97Ten thousand cases, accounting for the world18.2%Among them, the death toll is close to6Ten thousand cases.

conduct regularlyCervical liquid based cytology examinationIt is an effective method for early detection and prevention of cervical cancer. Cervical liquid based cytology examination requires pathologists to observe the morphology of tens of thousands of cells under a microscope, which heavily relies on the diagnostic experience of pathologists. At the same time, the large sample size of cervical cancer screening also poses a huge challenge to the number of pathologists in China.

Atypical squamous cells with unclear diagnostic significance（ASCUS）

High-grade squamous intraepithelial lesion cells（HSIL）

Low grade squamous intraepithelial lesion cells（LSIL）

mold

Now, Zeiss has partnered with DiYingJia Technology to launch a brand new productCervical cytology assisted diagnosis systemIt can automatically recognize cervical liquid based cell samples and quickly obtain full digital images. The cytology intelligent module analyzes the entire image in real-time, automatically locates suspicious lesion areas, and assists you in quickly completing cervical cancer screening and accurate diagnosis.

Zeiss Cervical Cytology Assisted Diagnosis System (jointly developed by Zeiss and DiYingJia Technology)

Assist you in efficiently completing screening and diagnosis work in one stop

Zeiss Cervical Cytology Assisted Diagnosis System CollectionPathological sections are fully digitized、Cytological assisted diagnosisandReal time review under the mirror integratedSeamless integration into the daily diagnostic work of doctors: become your "initial screening" assistant, improve the efficiency and detection rate of cervical cytology diagnosis. Further support the improvement of China's cervical cancer prevention and treatment capabilities, and care for the health of Chinese women.

• brand newLiquid based cell automated imaging platformExcellent optical quality, automatically recording the subtle differences of each cell in the sample

Flexible loading of multiple samples and Zeiss high-level20Objective lens scanning

• systemIntegrate the DiYingJia cervical cytology intelligent analysis moduleAutomatically generate suggested analysis results for whole field slicing, assisting doctors in screening out a large number of negative samples, while followingTBSDiagnostic criteria suggest multiple types of pathological cells and microbial infections

Quickly screen out negative samples

according toTBSDiagnostic criteria for identifying multiple types of diseased cells and microbial infections

• You can alsoQuickly view case detailsClick on the suspicious cell and the microscope will locate it in real-time to assist you in real-time microscopic review

Real time positioning, direct microscopic review and comparison

Policies related to the prevention and treatment of cervical cancer in China

✓ 2009In, cervical cancer and breast cancer“Two cancer screenings”Listed as a major public health project for women and children in China.

✓ 2019In the year,“Two cancer screenings”Include in the national basic public health service project.

✓ 2020Year: World Health Organization（WHO）The release of the Global Strategy to Accelerate the Elimination of Cervical Cancer marks a milestone for countries including China194A country and regionA unanimous commitment to eliminate a type of cancer.

✓ 2022year1In June, the Health Commission issued the Work Plan for Cervical Cancer Screening, which pointed out that we should actively use Internet, artificial intelligence and other technologies to improve the screening capacity of grass-roots cervical cancer.

About Diyingjia Technology

pathologyAIEnterprise, FocusAI+Digital pathology field20For over a year, we have provided complete solutions for the construction of digital, information-based, and intelligent pathology departments, covering various needs of the new generation of pathology department construction, assisting the development of pathology in China, and providing disease screening and accurate diagnosis solutions for Chinese patients. Through technological innovation, we aim to contribute to a healthy China.